Peptide drug discovery platform targeting oral bioavailability and GLP-1 class therapeutics
Protagonist is a public biotech company using a proprietary peptide-engineering platform to develop oral drugs in areas like metabolic disease and GI disorders. The tech stack reveals a mature, multi-modal development operation: HPLC-MS, LC-MS/MS, NONMEM, and Phoenix WinNonlin for pharmacokinetics; GraphPad Prism and Spotfire for data analysis; plus cloud infrastructure (AWS, Azure, GCP) and active AI/ML adoption (GPT, Gemini, MCP). The hiring velocity is accelerating with 17 roles posted in the last 30 days—60% research-heavy—and projects spanning solid-dose formulation, manufacturing scale-up, and clinical supply, signaling movement from discovery into late-stage development and manufacturing readiness.
Protagonist Therapeutics (Nasdaq: PTGX) is a public biopharmaceutical company focused on peptide-based drug discovery and development. Founded in 2006 and headquartered in Newark, California, the company operates a proprietary platform for de novo peptide discovery with engineered oral stability through peptidomimetic and chemical modifications. The 51–200 person team is currently executing across in vivo pharmacology studies, pharmacokinetic/pharmacodynamic evaluations, solid oral dosage form development, and clinical supply manufacturing. Active challenges include scaling manufacturing to meet regulatory chemistry, manufacturing, and controls (CMC) requirements; optimizing peptide oral delivery; and managing clinical trial recruitment and timelines.
Protagonist uses a proprietary platform for discovering peptides de novo with tailored potency, specificity, and selectivity, then engineers oral stability via peptidomimetic and chemical modifications to create oral peptide drugs.
HPLC-MS, LC-MS/MS, NONMEM, Phoenix WinNonlin, GraphPad Prism, Spotfire, ChemDraw, SciFinder, and cloud platforms (AWS, Azure, GCP). Also actively adopting GPT, Gemini, and MCP for AI-driven analysis and prototyping.
Other companies in the same industry, closest in size
Protagonist Therapeutics's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.